Eam Global Investors LLC Akero Therapeutics, Inc. Transaction History

Eam Global Investors LLC

  • $471 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$33.44 - $54.8 $737,385 - $1.21 Million
-22,051 Reduced 39.69%
33,509 $1.84 Million
Q3 2022

Nov 14, 2022
BUY
$10.15 - $34.05 $563,934 - $1.89 Million
55,560 New
55,560 $1.89 Million
Q4 2020

Feb 11, 2021
SELL
$25.12 - $29.89 $1.25 Million - $1.49 Million
-49,718 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$30.79 - $39.92 $1.53 Million - $1.98 Million
49,718 New
49,718 $1.53 Million

Others Institutions Holding AKRO

# of Institutions
210
Shares Held
74.3M
Call Options Held
321K
Put Options Held
558K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.08B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email